GlassScriptPhysician profile
Valluvan Jeevanandam
NPI 1285738344
$192,639.10
in general payments reported to CMS, 2019-2025
22 companies · $48K in 2025
The $48K reported for 2025 was more than what 97% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78K · 2020: $26K · 2021: $29K · 2022: $5,614 · 2023: $1,805 · 2024: $4,568 · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Travel and Lodging: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,670 · Food and Beverage: $3,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,467.50 |
| Travel and Lodging | $10,575.31 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,670.00 |
| Food and Beverage | $3,363.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $111,855.74 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Epic |
| Alexion Pharmaceuticals, INC. | $42,523.12 | 2023-2025 | Ultomiris |
| Zimmer Biomet Holdings, INC. | $10,537.40 | 2021-2024 | Sternalock Blu System |
| Ge Healthcare | $9,494.00 | 2024-2025 | |
| Baxter Healthcare | $7,998.30 | 2019-2025 | Preveleak |
| Sanofi-Aventis U.S. LLC | $5,250.00 | 2021 | |
| Astrazeneca Ab | $2,685.00 | 2022 | |
| Nihon Kohden America, LLC | $599.88 | 2019 | |
| Medtronic, INC. | $350.49 | 2021-2025 | Cardioblate Cryoflex, Cardioblate, Signia |
| Edwards Lifesciences Corporation | $260.73 | 2023-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Medtronic Vascular, INC. | $238.67 | 2019 | |
| Abiomed | $234.04 | 2021 | |
| Nuwellis, INC. | $155.05 | 2022 | |
| Medistim USA, INC. | $152.03 | 2021 | |
| Helios Cardio INC | $73.50 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $65.40 | 2024 | |
| Pfizer INC. | $64.92 | 2020-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.13 | 2019 | |
| Zoll Circulation INC | $35.32 | 2021 | |
| Lsi Solutions INC | $21.38 | 2024 | Cor-Knot |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valluvan Jeevanandam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.